These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14717786)

  • 1. The effects of selective cytokine inhibitory drugs (CC-10004 and CC-1088) on VEGF and IL-6 expression and apoptosis in myeloma and endothelial cell co-cultures.
    Molostvov G; Morris A; Rose P; Basu S; Muller G
    Br J Haematol; 2004 Feb; 124(3):366-75. PubMed ID: 14717786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.
    Gupta D; Treon SP; Shima Y; Hideshima T; Podar K; Tai YT; Lin B; Lentzsch S; Davies FE; Chauhan D; Schlossman RL; Richardson P; Ralph P; Wu L; Payvandi F; Muller G; Stirling DI; Anderson KC
    Leukemia; 2001 Dec; 15(12):1950-61. PubMed ID: 11753617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvesicles shed from bortezomib-treated or lenalidomide-treated human myeloma cells inhibit angiogenesis in vitro.
    Guo HM; Sun L; Yang L; Liu XJ; Nie ZY; Luo JM
    Oncol Rep; 2018 Jun; 39(6):2873-2880. PubMed ID: 29693175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma.
    Vacca A; Scavelli C; Montefusco V; Di Pietro G; Neri A; Mattioli M; Bicciato S; Nico B; Ribatti D; Dammacco F; Corradini P
    J Clin Oncol; 2005 Aug; 23(23):5334-46. PubMed ID: 15939924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of parthenolide on the angiogenesis induced by human multiple myeloma cells and the mechanism.
    Kong F; Chen Z; Li Q; Tian X; Zhao J; Yu K; You Y; Zou P
    J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):525-30. PubMed ID: 18846331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human multiple myeloma cells stimulate differentiation of endothelial cells to form capillary-like networks in two different co-culture systems].
    Wang YD; Hu Y; Sun CY; He WJ; Zhang XP
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):375-8. PubMed ID: 17939401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of thalidomide on Bcl2 expression and proangiogenic cytokine levels in short-term culture of peripheral blood and bone marrow mononuclear cells of multiple myeloma patients.
    Dmoszyńska A; Roliński J; Bojarska-Junak A; Mańko J; Jawniak D; Walter-Croneck A; Soroka-Wojtaszko M; Hus M
    Pol J Pharmacol; 2001; 53(6):709-13. PubMed ID: 11985351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential new therapeutics for Waldenstrom's macroglobulinemia.
    Zeldis JB; Schafer PH; Bennett BL; Mercurio F; Stirling DI
    Semin Oncol; 2003 Apr; 30(2):275-81. PubMed ID: 12720152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis.
    Sanda T; Kuwano T; Nakao S; Iida S; Ishida T; Komatsu H; Shudo K; Kuwano M; Ono M; Ueda R
    Leukemia; 2005 Jun; 19(6):901-9. PubMed ID: 15843826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The interaction of vascular endothelial growth factor and interleukin-6 in multiple myeloma].
    Zhang L; Chen SL; Chen WM; Liu JW
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):85-8. PubMed ID: 15840215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Human multiple myeloma cell line RPMI8226 activates brain derived neurotrophic factor autocrine loop of co-cultured endothelial cells].
    Wang YD; Hu Y; Sun CY; He WJ; Zhang XP
    Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):235-8. PubMed ID: 17877199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro inhibition and mechanism of multiple myeloma cells growth by thalidomide].
    Li J; Luo SK; Hong WD; Huang JQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):70-2. PubMed ID: 12513842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel biologically based therapies for myeloma.
    Anderson KC
    Cancer J; 2001; 7 Suppl 1():S19-23. PubMed ID: 11504280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucoidan inhibits angiogenesis induced by multiple myeloma cells.
    Liu F; Luo G; Xiao Q; Chen L; Luo X; Lv J; Chen L
    Oncol Rep; 2016 Oct; 36(4):1963-72. PubMed ID: 27498597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.
    Wang XQ; Zhou WJ; Luo XZ; Tao Y; Li DJ
    Hum Reprod; 2017 Jun; 32(6):1304-1317. PubMed ID: 28383711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thalidomide inhibits the angiogenic activity of culture supernatants of multiple myeloma cell line].
    Chen W; Zhu J; Mirshahi F; Soria J; Mirshahi M; Soria C
    Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):520-3. PubMed ID: 12482348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide and multiple myeloma serum synergistically induce a hemostatic imbalance in endothelial cells in vitro.
    Gao Y; Ma G; Liu S; Teng Y; Wang Y; Su Y
    Thromb Res; 2015 Jun; 135(6):1154-9. PubMed ID: 25840743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis.
    Giuliani N; Lunghi P; Morandi F; Colla S; Bonomini S; Hojden M; Rizzoli V; Bonati A
    Leukemia; 2004 Mar; 18(3):628-35. PubMed ID: 14737074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F; Das B
    Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin.
    Tanaka Y; Abe M; Hiasa M; Oda A; Amou H; Nakano A; Takeuchi K; Kitazoe K; Kido S; Inoue D; Moriyama K; Hashimoto T; Ozaki S; Matsumoto T
    Clin Cancer Res; 2007 Feb; 13(3):816-23. PubMed ID: 17289872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.